An scRNA-seq analysis of the transcriptomes of skin melanoma patients who received immune checkpoint inhibitors (ICIs) by Jerby-Arnon et al. revealed a panel of deregulated genes expressed by cancer cells, which are linked to the exclusion of CD8+ T cells and resistance to therapy [35]. This evidence concerns the gene CD8A and cutaneous melanoma.